Osaic Holdings
HBIO icon

Osaic Holdings’s Harvard Bioscience HBIO Stock Holding History

Osaic Holdings’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-122
Closed -$3.28K – 7511
2024
Q3 		$3.28K Hold
122
– – ﹤0.01% 6399
2024
Q2 		$3.47K Sell
122
-2,412
-95% -$84.6K ﹤0.01% 6353
2024
Q1 		$107K Buy
2,534
+2,524
+25,240% +$113K ﹤0.01% 4192
2023
Q4 		$535 Hold
10
– – ﹤0.01% 6882
2023
Q3 		$430 Hold
10
– – ﹤0.01% 7021
2023
Q2 		$549 Buy
+10
New +$549 ﹤0.01% 7028
2022
Q4 		– Sell
-210
Closed -$5K – 7286
2022
Q3 		$5K Sell
210
-122
-37% -$4.04K ﹤0.01% 6359
2022
Q2 		$12K Hold
332
– – ﹤0.01% 5962
2022
Q1 		$21K Hold
332
– – ﹤0.01% 5657
2021
Q4 		$24K Buy
332
+100
+43% +$7.11K ﹤0.01% 5670
2021
Q3 		$17K Buy
232
+72
+45% +$5.73K ﹤0.01% 5881
2021
Q2 		$13K Buy
160
+60
+60% +$4.25K ﹤0.01% 5907
2021
Q1 		$5K Buy
+100
New +$4.86K ﹤0.01% 6147
2020
Q4 		– Sell
-3
Closed – – 6467
2020
Q3 		$0 Sell
3
-67
-96% -$2.25K ﹤0.01% 6288
2020
Q2 		$2K Hold
70
– – ﹤0.01% 5786
2020
Q1 		$1K Buy
+70
New +$1.9K ﹤0.01% 5855

Other funds holding HBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Osaic Holdings's HBIO Position: Q4 2024 in Review

Osaic Holdings sold out of Harvard Bioscience (HBIO) in Q4 2024, closing a stake of 122 shares — an estimated $3.28K sold.

Osaic Holdings first reported a position in HBIO in Q1 2020 and held it in 16 quarters. The position peaked at $107K in Q1 2024. 95 funds tracked by Wall St. Rank hold HBIO as of Q4 2024.

  • Osaic Holdings reported no remaining Harvard Bioscience position as of Q4 2024 after selling out during the quarter.
  • Osaic Holdings sold 122 Harvard Bioscience shares in Q4 2024, an estimated $3.28K.
  • Osaic Holdings first reported a position in Harvard Bioscience in Q1 2020 and held it in 16 quarters.
  • Osaic Holdings's Harvard Bioscience position peaked at $107K in Q1 2024.
  • 95 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2024.

Based on Osaic Holdings's 13F filing for Q4 2024, filed 7 Feb 2025.